TLR4 and arthritic joint disease: In agreement with this idea, it has been shown that the TLR4 ligand lipopolysachariden (LPS) is able to restore the development of K/BxN serum transfer arthritis in Il1r1−/− mice, which were protected from the development of pathology in the absence of LPS [37].